Archive

10.10.22 Together with seven partner organisations from across Europe, Consilium Scientific and the TranspariMED campaign released two reports taking a close look at how various national medicines regulators are enforcing clinical trial transparency rules, and the impact that regulatory engagement has had on actual trial reporting in different countries across Europe.
29.11.22 Only 6% of clinical trials in multiple myeloma include patients from Central and Eastern Europe (СЕЕ). Myeloma Patients Europe launches a report with Consilium Scientific's analytics on clinical trials in СЕЕ. See the report to learn about huge inequalities in access to clinical trials
Addressing access barriers to myeloma clinical trials in Central and Eastern Europe (CEE)

Search